Understanding chronic inflammatory and neuropathic pain

Jane P. Hughes; Iain Chessell; Richard Malamut; Martin Perkins; Miroslav Bačkonja; Ralf Baron; John T. Farrar; Mark J. Field; Robert W. Gereau; Ian Gilron; Stephen B. Mcmahon; Frank Porreca; Bob A. Rappaport; Frank Rice; Laura K. Richman; Märta Segerdahl; David A. Seminowicz; Linda R. Watkins; Stephen G. Waxman; Katja Wiech; Clifford Woolf

doi:10.1111/j.1749-6632.2012.06561.x

Understanding chronic inflammatory and neuropathic pain

Jane P. Hughes, Iain Chessell, Richard Malamut, Martin Perkins, Miroslav Bačkonja, Ralf Baron, John T. Farrar, Mark J. Field, Robert W. Gereau, Ian Gilron, Stephen B. Mcmahon, Frank Porreca, Bob A. Rappaport, Frank Rice, Laura K. Richman, Märta Segerdahl, David A. Seminowicz, Linda R. Watkins, Stephen G. Waxman, Katja WiechClifford Woolf

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

This meeting report highlights the main topics presented at the conference "Chronic Inflammatory and Neuropathic Pain," convened jointly by the New York Academy of Sciences, MedImmune, and Grünenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain.

Original language	English (US)
Pages (from-to)	30-44
Number of pages	15
Journal	Annals of the New York Academy of Sciences
Volume	1255
Issue number	1
DOIs	https://doi.org/10.1111/j.1749-6632.2012.06561.x
State	Published - May 2012

ASJC Scopus subject areas

General Neuroscience
General Biochemistry, Genetics and Molecular Biology
History and Philosophy of Science

Access to Document

10.1111/j.1749-6632.2012.06561.x

Cite this

Hughes, J. P., Chessell, I., Malamut, R., Perkins, M., Bačkonja, M., Baron, R., Farrar, J. T., Field, M. J., Gereau, R. W., Gilron, I., Mcmahon, S. B., Porreca, F., Rappaport, B. A., Rice, F., Richman, L. K., Segerdahl, M., Seminowicz, D. A., Watkins, L. R., Waxman, S. G., ... Woolf, C. (2012). Understanding chronic inflammatory and neuropathic pain. Annals of the New York Academy of Sciences, 1255(1), 30-44. https://doi.org/10.1111/j.1749-6632.2012.06561.x

Hughes, JP, Chessell, I, Malamut, R, Perkins, M, Bačkonja, M, Baron, R, Farrar, JT, Field, MJ, Gereau, RW, Gilron, I, Mcmahon, SB, Porreca, F, Rappaport, BA, Rice, F, Richman, LK, Segerdahl, M, Seminowicz, DA, Watkins, LR, Waxman, SG, Wiech, K & Woolf, C 2012, 'Understanding chronic inflammatory and neuropathic pain', Annals of the New York Academy of Sciences, vol. 1255, no. 1, pp. 30-44. https://doi.org/10.1111/j.1749-6632.2012.06561.x

@article{0c2e8ada1fc44364a8a34e5a6cde506c,

title = "Understanding chronic inflammatory and neuropathic pain",

abstract = "This meeting report highlights the main topics presented at the conference {"}Chronic Inflammatory and Neuropathic Pain,{"} convened jointly by the New York Academy of Sciences, MedImmune, and Gr{\"u}nenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain.",

author = "Hughes, {Jane P.} and Iain Chessell and Richard Malamut and Martin Perkins and Miroslav Ba{\v c}konja and Ralf Baron and Farrar, {John T.} and Field, {Mark J.} and Gereau, {Robert W.} and Ian Gilron and Mcmahon, {Stephen B.} and Frank Porreca and Rappaport, {Bob A.} and Frank Rice and Richman, {Laura K.} and M{\"a}rta Segerdahl and Seminowicz, {David A.} and Watkins, {Linda R.} and Waxman, {Stephen G.} and Katja Wiech and Clifford Woolf",

year = "2012",

month = may,

doi = "10.1111/j.1749-6632.2012.06561.x",

language = "English (US)",

volume = "1255",

pages = "30--44",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Understanding chronic inflammatory and neuropathic pain

AU - Hughes, Jane P.

AU - Chessell, Iain

AU - Malamut, Richard

AU - Perkins, Martin

AU - Bačkonja, Miroslav

AU - Baron, Ralf

AU - Farrar, John T.

AU - Field, Mark J.

AU - Gereau, Robert W.

AU - Gilron, Ian

AU - Mcmahon, Stephen B.

AU - Porreca, Frank

AU - Rappaport, Bob A.

AU - Rice, Frank

AU - Richman, Laura K.

AU - Segerdahl, Märta

AU - Seminowicz, David A.

AU - Watkins, Linda R.

AU - Waxman, Stephen G.

AU - Wiech, Katja

AU - Woolf, Clifford

PY - 2012/5

Y1 - 2012/5

N2 - This meeting report highlights the main topics presented at the conference "Chronic Inflammatory and Neuropathic Pain," convened jointly by the New York Academy of Sciences, MedImmune, and Grünenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain.

AB - This meeting report highlights the main topics presented at the conference "Chronic Inflammatory and Neuropathic Pain," convened jointly by the New York Academy of Sciences, MedImmune, and Grünenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain.

UR - http://www.scopus.com/inward/record.url?scp=84860621032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860621032&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2012.06561.x

DO - 10.1111/j.1749-6632.2012.06561.x

M3 - Article

C2 - 22564068

AN - SCOPUS:84860621032

SN - 0077-8923

VL - 1255

SP - 30

EP - 44

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

IS - 1

ER -

Understanding chronic inflammatory and neuropathic pain

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this